Otitis Externa Clinical Trial
Official title:
Topical Voltaren as an Alternative Treatment for Otitis Externa
Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00872209 -
Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
|
Phase 1/Phase 2 | |
Recruiting |
NCT05370209 -
Performance and Safety of Otinova® Ear Spray
|
N/A | |
Completed |
NCT02558738 -
Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations
|
N/A | |
Completed |
NCT02511561 -
OTO-201 for the Treatment of Otitis Externa
|
Phase 2 | |
Terminated |
NCT01910155 -
A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
|
Phase 3 | |
Completed |
NCT01359098 -
Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
|
Phase 2 | |
Completed |
NCT01157819 -
Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
|
Phase 2 | |
Completed |
NCT00980876 -
A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
|
Phase 3 |